This article is more than 5 years old. Information may no longer be current.

Fox Chase Cancer Center appoints assistant professor

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Jason A. Incorvati, MD, has been appointed assistant professor in the department of hematology/oncology at Fox Chase Cancer Center.

Incorvati will treat patients at Fox Chase Cancer Center East Norriton Hospital Outpatient Center, scheduled to open in early 2018. He also will see patients with breast cancer at the main Fox Chase campus.

His appointment will take effect Jan. 1.

Incorvati received his medical degree from Temple University School of Medicine. He completed his residency in internal medicine at University of Maryland, and he completed a fellowship in hematology/oncology at State University of New York at Stony Brook.

He is board certified in internal medicine, medical oncology, and hematology. He has been involved in several clinical trials.

“We’re excited for Dr. Incorvati to join our team at Fox Chase,” Martin Edelman, MD, chair of the department of hematology/oncology, said in a press release. “He brings extensive real-world clinical experience, coupled with a strong interest in clinical research. I am confident he will be a great fit for our team and a fantastic asset at our new East Norriton campus.”